Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
article has not abstract
Vyšlo v časopise:
Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis. PLoS Med 10(10): e32767. doi:10.1371/journal.pmed.1001537
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001537
Souhrn
article has not abstract
Zdroje
1. PatelVB, TheronG, LendersL, MatinyenyaB, ConnollyC, et al. (2013) Quantitative PCR (GeneXpert MTB/RIF) for the diagnosis of tuberculous meningitis in HIV-infected patients from a high burden setting: a prospective study. PLoS Med 10 ((10)) e1001536 doi:10.1371/journal.pmed.1001536
2. BlakemoreR, StoryE, HelbD, KopJ, BanadaP, et al. (2010) Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 48: 2495–2501.
3. HelbD, JonesM, StoryE, BoehmeC, WallaceE, et al. (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48: 229–237.
4. RajaS, ChingJ, XiL, HughesSJ, ChangR, et al. (2005) Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem 51: 882–890.
5. World Health Organization (2013) WHO monitoring of Xpert MTB/RIF roll-out. Available: http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html. Accessed 1 September 2013.
6. Foundation for Innovative New Diagnostics (2013) Negotiated prices for Xpert® MTB/RIF and FIND country list. Available: http://www.finddiagnostics.org/about/what_we_do/successes/find-negotiated-prices/xpert_mtb_rif.html. Accessed 1 September 2013.
7. American Thoracic Society (2000) Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161: 1376–1395.
8. HobbyGL, HolmanAP, IsemanMD, JonesJM (1973) Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 4: 94–104.
9. van Zyl-SmitRN, BinderA, MeldauR, MishraH, SemplePL, et al. (2011) Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden. PLoS ONE 6 ((12)) e28815 doi:10.1371/journal.pone.0028815
10. BoehmeCC, NabetaP, HillemannD, NicolMP, ShenaiS, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005–1015.
11. ChangK, LuW, WangJ, ZhangK, JiaS, et al. (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64: 580–588.
12. VadwaiV, BoehmeC, NabetaP, ShettyA, AllandD, et al. (2011) Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 49: 2540–2545.
13. TortoliE, RussoC, PiersimoniC, MazzolaE, Dal MonteP, et al. (2012) Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 40: 442–447.
14. PaiM, FloresLL, PaiN, HubbardA, RileyLW, et al. (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3: 633–643.
15. DurskiKN, KuntzKM, YasukawaK, VirnigBA, MeyaDB, et al. (2013) Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr 63: e101–e108.
16. ThwaitesGE, ChauTT, StepniewskaK, PhuNH, ChuongLV, et al. (2002) Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360: 1287–1292.
17. KumarR, SinghSN, KohliN (1999) A diagnostic rule for tuberculous meningitis. Arch Dis Child 81: 221–224.
18. MaraisS, ThwaitesG, SchoemanJF, TorokME, MisraUK, et al. (2010) Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 10: 803–812.
19. van WellGT, PaesBF, TerweeCB, SpringerP, RoordJJ, et al. (2009) Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 123: e1–e8.
20. GirgisNI, SultanY, FaridZ, MansourMM, ErianMW, et al. (1998) Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 58: 28–34.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 10
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
- Modelling the Strategic Use of Antiretroviral Therapy for the Treatment and Prevention of HIV
- Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective Study
- Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study